Pharmacology

Relevant Content

Letter by Dai et al Regarding Article, “Coramitug, a Humanized Monoclonal Antibody for the Treatment of Transthyretin Amyloid Cardiomyopathy: A Phase 2, Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial”

Circulation, Volume 154, Issue 12, Page e405-e406, September 22, 2026. Clinical Management of Myocardial Infarction

Circulation, Volume 154, Issue 11, Page 1036-1051, September 15, 2026. Introduction to Hypertensive Disorders Associated with Pregnancy

Clinical Benefits Associated With Evinacumab in Pediatric Patients With Homozygous Familial Hypercholesterolemia

Journal of the American Heart Association, Ahead of Print.
Background...

Intracoronary Low-Dose Thrombolysis in Primary PCI for STEMI: A Systematic Review and Meta-Analysis

Circulation: Cardiovascular Interventions, Ahead of Print.

2026 AHA/ACC Clinical Performance and Quality Measures for Patients With Atrial Fibrillation

Stroke ... Communities ... ASCVD Risk Calculator HCM-AF Risk Calculator Combined Adult/Pediatric Hypertrophic Cardiomyopathy Calculator for Risk of Sudden ... HCM SCD Risk Calculator

Natural ERRα Activator Formononetin Ameliorates Anthracycline Cardiotoxicity via Metabolic Improvement

Circulation Research, Ahead of Print.
BACKGROUND:Anthracycline-induce...

Letter by Wang and Wang Regarding Article, “Cardiac Allograft Vasculopathy Inhibition With Alirocumab: The CAVIAR Trial”

Circulation, Volume 154, Issue 5, Page e185-e186, August 4, 2026.

Methodologic Standards for Follow-Up Extension in Cardiovascular Trials

Extension follow-up studies address long-term questions beyond the parent...

Association of SGLT2 Inhibitor Use With Outcomes in Patients With Frailty Hospitalized for Acute Heart Failure: Insights From a Multicenter Japanese Registry

Journal of the American Heart Association, Volume 15, Issue 15, August 4,...